Merios
Supplements

Omega-3 Index: The Blood Test That Predicts Heart Disease Better Than Cholesterol

What the omega-3 index measures, why a score above 8% dramatically lowers cardiovascular risk, how to test it, and the best ways to raise your level.

APR 17, 20269 MIN READSUPPLEMENTSMERIOS EDITORIAL
Omega-3 Index: The Blood Test That Predicts Heart Disease Better Than Cholesterol
Contents
  1. What the omega-3 index measures
  2. The risk zones
  3. What the research shows
  4. Why most people are deficient
  5. How to raise your omega-3 index
  6. Dietary approach
  7. Supplementation
  8. Timeline
  9. Omega-3 and other biomarkers
  10. Common questions
  11. How Merios helps

There is a blood test that costs under $100, predicts cardiovascular risk better than many standard markers, reflects your nutritional status over the past four months, and almost nobody orders it.

It is called the omega-3 index, and it measures the percentage of EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) in your red blood cell membranes.

The number tells you, quite directly, whether your cells are protected or vulnerable.

What the omega-3 index measures

Unlike a standard cholesterol panel that measures lipids floating in your plasma, the omega-3 index looks at what is built into your cell membranes. Red blood cells incorporate the omega-3 fatty acids you consume into their phospholipid bilayer. The more EPA and DHA you eat (from fish, seafood, or supplements), the higher the percentage in your membranes.

This matters because cell membrane composition affects everything: membrane fluidity, inflammation signaling, ion channel function, and the behavior of every receptor that sits in the membrane. Your cells literally function differently depending on this ratio.

The omega-3 index is expressed as a percentage:

Omega-3 Index = (EPA + DHA in red blood cell membranes) ÷ (Total fatty acids in red blood cell membranes) × 100

The risk zones

Dr. William Harris and Dr. Clemens von Schacky proposed the omega-3 index as a cardiovascular risk factor in 2004. Their framework:

Omega-3 IndexRisk zoneContext
Above 8%Low risk — optimalTypical of Japanese and Korean populations with high seafood intake
4–8%Intermediate riskWhere most supplement-takers land
Below 4%High riskComparable to smoking as a cardiovascular risk factor

The average American omega-3 index is roughly 4–5%. In Japan, it averages 8–11%. This is not coincidental — it tracks closely with the dramatically lower rates of sudden cardiac death in Japanese populations.

What the research shows

The evidence for the omega-3 index as a health predictor is extensive:

Cardiovascular mortality: The Framingham Offspring Study followed 2,500 adults and found those in the highest omega-3 index quintile had a 34% lower risk of all-cause mortality compared to the lowest quintile. The effect was strongest for cardiovascular death.

Sudden cardiac death: Harris's original research showed that an omega-3 index above 8% was associated with a 90% reduction in risk of sudden cardiac death compared to an index below 4%. Sudden cardiac death accounts for roughly half of all cardiac deaths.

Heart failure: A 2021 meta-analysis found higher omega-3 index associated with lower risk of incident heart failure and better outcomes in existing heart failure patients.

Brain health: DHA constitutes approximately 40% of the polyunsaturated fatty acids in the brain. Higher omega-3 index has been associated with larger brain volume, reduced brain aging, and lower risk of dementia in observational studies.

Inflammation: EPA and DHA are precursors to resolvins and protectins — molecules that actively resolve inflammation. A higher omega-3 index is associated with lower hs-CRP and lower inflammatory cytokines.

Why most people are deficient

The human body cannot produce EPA and DHA efficiently. We can convert small amounts from ALA (alpha-linolenic acid, found in flaxseed and walnuts), but the conversion rate is extremely low — typically 5–10% for EPA and less than 1% for DHA. Practically speaking, you need to get EPA and DHA directly from:

  • Fatty fish: salmon, mackerel, sardines, anchovies, herring
  • Shellfish: oysters, mussels
  • Fish oil or algae oil supplements

The problem is that most Americans eat fish once a week or less. And the fish they eat tends to be lean (tilapia, shrimp, cod) rather than fatty fish rich in omega-3s. Meanwhile, omega-6 fatty acid intake (from vegetable oils in processed food) has increased dramatically, pushing the omega-6/omega-3 ratio from a historical ~2:1 toward 15:1 or even 20:1.

How to raise your omega-3 index

Dietary approach

Eating fatty fish 3–4 times per week can maintain an omega-3 index above 8%. The highest EPA+DHA sources per serving:

Fish (3 oz serving)EPA + DHA (mg)
Atlantic mackerel2,500
Wild salmon1,800
Sardines1,400
Anchovies1,300
Herring1,700
Rainbow trout1,000
Oysters (6 medium)600

For comparison, tilapia has about 130 mg per serving — you would need to eat a pound daily to match a single serving of mackerel.

Supplementation

For most people, supplementation is the practical path to an omega-3 index above 8%:

  • Target dose: 2–3 grams of combined EPA+DHA per day (not total fish oil — read the label for EPA+DHA content specifically)
  • Form matters: triglyceride form fish oil has better absorption than ethyl ester form. Look for "TG form" or "re-esterified triglyceride" on the label
  • Take with fat: omega-3 absorption increases 3x when taken with a meal containing fat
  • Algae oil: for vegetarians/vegans, algae-derived DHA+EPA supplements are effective and sustainable
  • Quality: choose brands that are IFOS-certified (International Fish Oil Standards) for purity and freshness

Timeline

Because the omega-3 index reflects red blood cell membrane composition, and red blood cells have a lifespan of about 120 days, expect to see changes over 3–4 months of consistent intake. Retest at 4 months to see where you land.

Omega-3 and other biomarkers

The omega-3 index interacts with several other markers Merios tracks:

  • Triglycerides: high-dose EPA+DHA (3–4 g/day) can lower triglycerides by 25–30%. The REDUCE-IT trial showed that 4 g/day of icosapent ethyl (pure EPA) reduced cardiovascular events by 25% in people with elevated triglycerides.
  • hs-CRP: omega-3s lower systemic inflammation, often reflected in a decrease in hs-CRP.
  • Resting heart rate: omega-3 supplementation has been shown to lower resting heart rate by 2–4 bpm on average, likely through improved vagal tone.
  • HRV: some studies show improved heart rate variability with higher omega-3 status, consistent with enhanced parasympathetic function.

Common questions

Is there such a thing as too high an omega-3 index? There is no established upper limit of concern. Populations with very high seafood intake (Inuit, Japanese fishing communities) have omega-3 indices of 12–15% without adverse effects. The theoretical concern about bleeding risk at very high doses has not been confirmed in clinical trials.

Does the source matter — fish vs. supplement? Both work. The omega-3 index responds to total EPA+DHA intake regardless of source. Fish has the advantage of providing additional nutrients (selenium, vitamin D, protein). Supplements have the advantage of consistency and dose control.

What about krill oil? Krill oil contains EPA and DHA in phospholipid form, which some studies suggest has slightly better bioavailability. However, the EPA+DHA content per capsule is typically much lower than fish oil, so you need more capsules (and spend more money) to reach the same dose.

How Merios helps

Upload your omega-3 index test results to Merios alongside your lipid panel, inflammatory markers, and Apple Watch data. Track how your omega-3 index changes over time as you adjust your diet and supplementation, and see it in context with your triglycerides, hs-CRP, resting heart rate, and HRV.

Track your omega-3 index with Merios →


This article is for informational purposes only and does not constitute medical advice. Discuss omega-3 supplementation with your physician, especially if you take blood-thinning medications.

Merios EditorialResearch-backed health insights from the Merios team
Share

Frequently asked questions

Newsletter

Like this? Get the next one in your inbox.

Early access includes our weekly briefing — new biomarker deep-dives, plain-English study breakdowns, nothing else.